BODI vs NRDS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 03, 2026
BODI
NRDS
Investment Advisor Scores
NRDS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | BODI | NRDS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 26.1097 | 10.352 | NRDS |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -25.0% | 6.2% | NRDS |
| Earnings Growth | 0.0% | 10935.0% | NRDS |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 47.3/100 | 47.6/100 | NRDS |
| Profit Margin | 2.2% | 8.1% | NRDS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BODI
DistributionPrice near a flattening SMA50 (slope -10.1%) with fading momentum, RSI 44
NRDS
DistributionPrice near a flattening SMA50 (slope -1.4%) with fading momentum, RSI 49
Fundamentals Snapshot
| Metric | BODI | NRDS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 9.7 | 4.4 |
| Trailing P/E | 13.4 | 9.7 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.3% | 0.1% |
| Gross Margin | 0.7% | 0.9% |
| Operating Margin | 0.1% | 0.1% |
| EPS | 0.73 | 0.93 |
| Dividend Yield | — | — |